Literature DB >> 7890405

Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis.

D A Rouse1, S L Morris.   

Abstract

Genetic and biochemical studies have suggested a link between reduced catalase activity and resistance to isoniazid in Mycobacterium tuberculosis. In this study, we examined the molecular mechanisms of resistance to isoniazid with six in vitro mutants of the M. tuberculosis complex (Mycobacterium bovis and M. tuberculosis). Five of six mutants resistant to isoniazid were negative by catalase assays. Immunoblot analyses using a polyclonal antibody against the katG gene product (catalase-peroxidase) demonstrated that the enzyme is not produced in four of these isoniazid-resistant strains. A complete deletion of the katG gene was detected in only one of these isoniazid-resistant M. tuberculosis complex strains by Southern blot analyses. In two other resistant strains, partial deletions of the katG gene were identified. A point mutation which resulted in the insertion of a termination codon in the katG coding sequence caused a catalase-negative phenotype in a fourth strain. Of the two resistant strains which produce the enzyme, one was shown to be negative by a catalase assay. Single-stranded conformational polymorphism and DNA sequence analyses identified a mutation in the katG gene of this strain which may contribute to reduced enzymatic activity and subsequent isoniazid resistance. These data demonstrate that genetic alterations to the katG gene other than complete deletions are prevalent and may contribute significantly to the number of cases of isoniazid-resistant tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890405      PMCID: PMC173170          DOI: 10.1128/iai.63.4.1427-1433.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Pigments produced by Mycobacteria on exposure to isoniazid. 2.

Authors:  J YOUATT
Journal:  Aust J Exp Biol Med Sci       Date:  1962-06

2.  Catalase and peroxidase in mycobacteria. Possible relationship to the mode of action of isoniazid.

Authors:  F WINDER
Journal:  Am Rev Respir Dis       Date:  1960-01

3.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

4.  An enzyme system of Mycobacterium tuberculosis that reacts specifically with isoniazid. I.

Authors:  J Youatt; S H Tham
Journal:  Am Rev Respir Dis       Date:  1969-07

5.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.

Authors:  A Telenti; P Imboden; F Marchesi; D Lowrie; S Cole; M J Colston; L Matter; K Schopfer; T Bodmer
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

Review 6.  Tuberculosis: the return of an old enemy.

Authors:  F M Collins
Journal:  Crit Rev Microbiol       Date:  1993       Impact factor: 7.624

7.  The catalase-peroxidase of Mycobacterium intracellulare: nucleotide sequence analysis and expression in Escherichia coli.

Authors:  S L Morris; J Nair; D A Rouse
Journal:  J Gen Microbiol       Date:  1992-11

8.  Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations.

Authors:  Y Zhang; T Garbe; D Young
Journal:  Mol Microbiol       Date:  1993-05       Impact factor: 3.501

9.  Production, characterization, and species specificity of monoclonal antibodies to Mycobacterium avium complex protein antigens.

Authors:  D A Rouse; S L Morris; A B Karpas; P G Probst; S D Chaparas
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

10.  The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.

Authors:  Y Zhang; B Heym; B Allen; D Young; S Cole
Journal:  Nature       Date:  1992-08-13       Impact factor: 49.962

View more
  16 in total

1.  Rapid identification of mycobacteria and drug-resistant Mycobacterium tuberculosis by use of a single multiplex PCR and DNA sequencing.

Authors:  Ailyn C Pérez-Osorio; David S Boyle; Zachary K Ingham; Alla Ostash; Romesh K Gautom; Craig Colombel; Yolanda Houze; Brandon T Leader
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  Exploring the structure and function of the mycobacterial KatG protein using trans-dominant mutants.

Authors:  Joseph A DeVito; Sheldon Morris
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis.

Authors:  S Dhandayuthapani; Y Zhang; M H Mudd; V Deretic
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

4.  Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan.

Authors:  H Ohno; H Koga; S Kohno; T Tashiro; K Hara
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

5.  katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients.

Authors:  H J Marttila; H Soini; P Huovinen; M K Viljanen
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

6.  Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities.

Authors:  S Sreevatsan; X Pan; Y Zhang; V Deretic; J M Musser
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

7.  Structure of Mycobacterium tuberculosis thioredoxin in complex with quinol inhibitor PMX464.

Authors:  Gareth Hall; Tracey D Bradshaw; Charles A Laughton; Malcolm F Stevens; Jonas Emsley
Journal:  Protein Sci       Date:  2011-01       Impact factor: 6.725

8.  Mycobacterium tuberculosis efpA encodes an efflux protein of the QacA transporter family.

Authors:  J L Doran; Y Pang; K E Mdluli; A J Moran; T C Victor; R W Stokes; E Mahenthiralingam; B N Kreiswirth; J L Butt; G S Baron; J D Treit; V J Kerr; P D Van Helden; M C Roberts; F E Nano
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

9.  Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid.

Authors:  Y Zhang; S Dhandayuthapani; V Deretic
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

10.  Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.

Authors:  D A Rouse; Z Li; G H Bai; S L Morris
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.